Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$253.1M
3 rounds on record
Latest round
$107M
Series B · Jan 2026 · 8 mo ago
Team
38
US Form 5500 (plan participants) · Dec 2025 · +12% in a year
Backers
2
Novartis Venture Fund, Taiho Ventures
The money's age
Fresh money
8 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 7
Raised a round Series B $107M
Jul 19, 2023
New executive EpiBiologics Appoints Ann Lee-Karlon as Chief Executive Officer and President, Extends Series A Financing to Over $70 Million · businesswire.com
Mar 21, 2022
Raised a round Venture round $73.1M · SEC Form D
Mar 21, 2022
Raised a round Series A $73.1M · SEC Form D
2021
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series B | Jan 2026 | $107M | — | businesswire.com |
| Venture round | Mar 2022 | $73.1M | — | SEC Form D |
| Series A | Mar 2022 | $73.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | EpiBiologics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Mitchell MutzExecutive Officer, DirectorSEC Form D
Rami HannoushExecutive Officer, DirectorSEC Form D
Craig LichtensteinExecutive OfficerSEC Form D
Ann Lee-KarlonExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

OUR STORY Seyed Tabatabaei and Mona Molaasgari cofounded mmTron in 2020. Seyed serves as chairman of the board and chief executive officer…

Home About us Our Team Our Product Pipeline Our Supporters Science & Technology Publications Contact Us Our Team Lalit Pai Chief Executive…

Home About Login Our Founders Rafay Khan Chief Executive Officer Steve Milton Chief Product Officer Our Mission We're passionate about…

Dialog window Kevin Didden Chief Executive Officer and Founder Kevin Didden founded the company in 1996. Since that time, CiDRA has…

× Dr. Rachel Abbott Chief Executive Officer Rachel Abbott joined Pan Cancer T in January 2023 as Chief Scientific Officer, bringing a…

Operational Support Built for Today's CEO XpertLoop Operators are fractional partners to the chief executive. They put the Chief Executive…
News
EpiBiologics Doses First Patient with EPI-326 Bispecific Antibody in Global Phase 1 Study for EGFR-Driven Solid Tumors
Read more
Report
EpiBiologics: $107 Million Series B Raised To Advance Tissue-Selective EGFR Degrader And Bispecific Antibody Pipeline
EpiBiologics announced it has closed a $107 million Series B financing to advance a pipeline of bispecific antibodies designed to selectively degrade extracellular protein targets in oncology and immunology. The round was co-led by GV and Johnson & Johnso
Read more
Report
EpiBiologics Closes $107M Series B to Advance Pipeline of Novel Bispecific Antibodies to Selectively Degrade Extracellular Protein Targets in Oncology and Immunology
EpiBiologics Closes $107M Series B to Advance Pipeline of Novel Bispecific Antibodies to Selectively Degrade Extracellular Protein Targets in Oncology and Immunology
Read more
Report
EpiBiologics Closes $107M Series B to Advance Pipeline of Novel Bispecific Antibodies to Selectively Degrade Extracellular Protein Targets in Oncology and Immunology
Read more
Report
EpiBiologics: Protein Degradation Platform Company Closes Over $70 Million
EpiBiologics - a biotechnology company advancing a next-generation antibody-based protein degradation platform and pipeline for membrane and extracellular drug targets - recently announced the company brought the total series A round to $73 million with t
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People

Mitchell Mutz
Executive Officer, Director

Rami Hannoush
Executive Officer, Director

Craig Lichtenstein
Executive Officer

Ann Lee-Karlon
Executive Officer, Director

Alexandra Cantley
Director

Michael Kavanaugh
Director

James Wells
Director

Jason Coloma
Director

Samuel Bjork
Director

Seiji Miyahara
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Mateo
United States
HQ
Contact Us
50-200 est. staff
Suite 250, San Mateo, CA 94403

Novartis Venture Fund
Taiho Ventures